Welcome to our website!|Hot Line: 86-21-31433387|E-mail:
Products Category
Contact Us
Tel: +86-21-31433387
QQ: 1369748377
Home > Products > Angiogenesis
Cat.No. Product name Product Description
R10001 R788; Fostamatinib Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor
R10002 R406 Free base R406 (free base) is a potent Syk inhibitor with IC50 of 41 nM in a cell-free ass
R10097 GNF-2 GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no a
R10124 Ibrutinib;PCI-32765 Ibrutinib (PCI-32765) is a potent and highly selective Brutons tyrosine kinase (
R10181 AP24534; Ponatinib Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VE
R10204 PF562271 PF-562271 is a potent, ATP-competitive, reversible inhibitor of FAK wi
R10334 SU6656 SU 6656 is a selective Src family kinase inhibitor with IC50 of 280 nM, 20 nM, 1
R10367 NVPTAE226 TAE226 (NVP-TAE226) is a potent FAK inhibitor with IC50 of 5.5 nM and modestly p
R10496 Dasatinib;BMS-354825;BMS354825 Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src
R10503 Nilotinib; AMN-107 Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM in Murine m
R10677 WH-4-023 WH-4-023 is a potent and orally active Lck/Src inhibitor with IC50 of 2 nM and 6
R10831 Dasatinib monohydrate Dasatinib Monohydrate is a novel, potent and multi-targeted inhibitor that targe
R10873 CNX-774 CNX-774 is an irreversible, orally active, and highly selective BTK inhibitor wi
R10875 Entospletinib (GS-9973) Entospletinib (GS-9973) is an orally bioavailable, selective Syk inhibitor with
R10917 Radotinib; IY-5511 Radotinib(IY-5511) is a novel and selective BCR-ABL1 tyrosine kinase inhibitor w
R10967 PF-431396 PF-431396 is a dual PYK2/FAK inhibitor with IC50 of 11 nM and 2 nM, respectively
R10997 GNF-7 GNF-7 is a potent type-II kinase Bcr-Abl inhibitor with IC50 of <5 nM, 61 nM,
R11448 Fostamatinib Disodium (Synonyms: R788(Disodium)) R788 (Fostamatinib) disodium, a prodrug of the active metabolite R406, is a Syk
R11633 GZD824 (Synonyms: HQP1351) GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(W
R11585 BAY 61-3606 dihydrochloride BAY 61-3606 dihydrochloride is an orally available, ATP-competitive, reversible
R912032 jnd3229 JND3229 is a New EGFRC797S Mutant Inhibitor with In Vivo Monodrug Efficacy (IC50
R2032482 Pacritinib(SB1518) Pacritinib is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V61
Page 1 / Total 1 FirstPrevNextLastGoto